Metabolic Diseases  >>  cyclosporine  >>  Phase 3
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
cyclosporine / Generic mfg.
NCT01762657: The Insulin Independence Trial (IIT) Evaluating the Safety and Efficacy of Oral Cyclosporine and Oral Lansoprazole for Insulin Independence Among Patients With Existing Type 1 Diabetes

Withdrawn
3
0
US
Oral Cyclosporine and Oral Lansoprazole, Placebos
Perle Bioscience, Inc.
Type 1 Diabetes
09/15
09/15
NCT01762644 / 2015-000105-39: The Insulin Independence Trial (IIT) Evaluating the Safety and Efficacy of Oral Cyclosporine and Oral Omeprazole for Insulin Independence Among Recent Onset Type 1 Diabetes Patients

Withdrawn
2b/3
0
Europe, RoW
Oral Cyclosporine and Oral Omeprazole, Oral Omeprazole
Perle Bioscience, Inc., Syreon Corporation
Type 1 Diabetes
05/16
08/16

Download Options